Aptamer-based capture molecules as a novel coating strategy to promote cell adhesion

Journal of Cellular and Molecular Medicine

Volumn 9, Issue 3, 2005, Pages 731-736

  Guo, Ketai ^a   Wendel, Hans P ^a,b   Scheideler, Lutz ^a   Ziemer, Gerhard ^a   Scheule, Albertus M ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b NONE   (Germany)

Author keywords

Aptamer; Implant; Osteoblast; Tissue engineering

Indexed keywords

DNA; PRIMER DNA;

ARTICLE; CELL ADHESION; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; CYTOLOGY; FLOW CYTOMETRY; HUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PHYSIOLOGY; PROSTHESES AND ORTHOSES; ULTRASTRUCTURE;

BASE SEQUENCE; CELL ADHESION; CELL LINE; DNA; DNA PRIMERS; FLOW CYTOMETRY; HUMANS; MODELS, MOLECULAR; NUCLEIC ACID CONFORMATION; OSTEOBLASTS; PROSTHESES AND IMPLANTS;

EID: 27744538924     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1115/1.1954791     Document Type: Review

References (26)

1. Raeber GP, Lutolf MP, Hubbell JA. Molecularly engineered PEG hydrogels: a novel model system for proteolytically-mediated cell migration. Biophys J. 2005; 89: 1374-88.
2. Fittkau MH, Zilla P, Bezuidenhout D. The selective modulation of endothelial cell mobility on RGD peptide containing surfaces by YIGSR peptides. Biomaterials 2005; 26: 167-74
3. Yang F, Williams CG, Wang DA. The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells. Biomaterials 2005; 26: 5991-8.
4. Seliktar D, Zisch AH, Lutolf MP. MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing. J Biomed Mater Res A. 2004 15; 68: 704-16.
5. Schmockel HG, Weber FE, Hurter K. Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats. J Small Anim Pract. 2005; 46: 17-21.
6. Park YJ, Kim KH, Lee JY. Immobilization of bone morphogenetic protein-2 onto a nanofibrous chitosan membrane for enhanced guided bone regeneration. Biotechnol Appl Biochem. 2005.
7. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505-10.
8. Gold L, Polisky B, Uhlenbeck O. Diversity of oligonucleotide functions. Annu Rev Biochem. 1995; 64: 763-97.
9. Gewirtz AM. Oligonucleotide therapeutics: clothing the emperor. Curr Opin Mol Ther. 1999; 1: 297-306.
10. Brody EN, Gold L. Aptamers as therapeutic and diagnostic agents. J Biotechnol. 2000; 74: 5-13.
11. Stadtherr K, Wolf H, Lindner P. An aptamer-based protein biochip. Anal Chem. 2005; 77: 3437-43.
12. Nimjee SM, Rusconi CP, Harrington RA. The potential of aptamers as anticoagulants. Trends Cardiovasc Med. 2005; 15: 41-5.
13. Jayasena SD. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem. 1999; 45: 1628-50.
14. Nimjee SM, Rusconi CP, Sullenger BA. Aptamers: an emerging class of therapeutics. Annu Rev Med. 2005; 56: 555-83.
15. Jeon SH, Kayhan B, Ben-Yedidia T. A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin. J Biol Chem. 2004; 279: 48410-9.
16. Cerchia L, Hamm J, Libri D, Tavitian B, de Franciscis V. Nucleic acid aptamers in cancer medicine. FEBS Lett. 2002; 528: 12-6.
17. Zhu X, Chen J., Scheideler L, Reichl R, Geis-Gerstorfer J. Effects of topography and composition of titanium surface oxides on osteoblast responses. Biomaterials 2004; 25: 4087-103
18. Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci. 2003; 100: 15416-20.
19. Blank M, Weinschenk T, Priemeri M, Schluesener H. Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels. J Biol Chem. 2001; 276: 16464-8.
20. Eder P, DeVine R, Dagle J, Walder J. Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 30 exonuclease in plasma. Antisense Res Dev. 1991; 1: 141-51.
21. Nimjee SM, Rusconi CP, Sullenger BA. Aptamers: an emerging class of therapeutics. Annu Rev Med. 2005; 18: 555-83.
22. Sen D. Aptamer rivalry. Chem Biol. 2002; 9: 851-2.
23. Shaun D, Mendonsa, Michael T. In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. Anal Chem. 2004; 76: 5387-92.
24. Hoppe-Seyler F, Crnkovic-Mertens I, Tomai E, Butz K. Peptide aptamers: specific inhibitors of protein function. Curr Mol Med. 2004; 4: 529-38.
25. Liu X, Cao G, Ding H, Zhang D, Yang G, Liu N, Fan M, Shen B, Shao N. Screening of functional antidotes of RNA aptamers against bovine thrombin. FEBS Lett. 2004; 562: 125-8.
26. Pratt AB, Weber FE, Schmoekel HG. Synthetic extracellular matrices for in situ tissue engineering. Biotechnol Bioeng. 2004; 86: 27-36.